Literature DB >> 26698322

Modeling the Time Course of the Tissue Responses to Intramuscular Long-acting Paliperidone Palmitate Nano-/Microcrystals and Polystyrene Microspheres in the Rat.

Nicolas Darville1, Marjolein van Heerden2, Tim Erkens3, Sandra De Jonghe3, An Vynckier3, Marc De Meulder3, An Vermeulen4, Patrick Sterkens3, Pieter Annaert5, Guy Van den Mooter5.   

Abstract

Long-acting injectable (LAI) drug suspensions consist of drug nano-/microcrystals suspended in an aqueous vehicle and enable prolonged therapeutic drug exposure up to several months. The examination of injection site reactions (ISRs) to the intramuscular (IM) injection of LAI suspensions is relevant not only from a safety perspective but also for the understanding of the pharmacokinetics. The aim of this study was to perform a multilevel temporal characterization of the local and lymphatic histopathological/immunological alterations triggered by the IM injection of an LAI paliperidone palmitate suspension and an analog polystyrene suspension in rats and identify critical time points and parameters with regard to the host response. The ISRs showed a moderate to marked chronic granulomatous inflammation, which was mediated by multiple cyto-/chemokines, including interleukin-1β, monocyte Chemoattractant Protein-1, and vascular endothelial growth factor. Lymphatic uptake and lymph node retention of nano-/microparticles were observed, but the contribution to the drug absorption was negligible. A simple image analysis procedure and empirical model were proposed for the accurate evaluation of the depot geometry, cell infiltration, and vascularization. This study was designed as a reference for the evaluation and comparison of future LAIs and to support the mechanistic modeling of the formulation-physiology interplay regulating the drug absorption from LAIs.
© The Author(s) 2015.

Entities:  

Keywords:  cytokines; inflammation; intramuscular; long-acting injectable; nano-/microparticles; paliperidone palmitate; quantitative histology

Mesh:

Substances:

Year:  2015        PMID: 26698322     DOI: 10.1177/0192623315618291

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  5 in total

1.  Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation.

Authors:  Suyash Deodhar; Brady Sillman; Aditya N Bade; Sean N Avedissian; Anthony T Podany; JoEllyn M McMillan; Nagsen Gautam; Brandon Hanson; Bhagya L Dyavar Shetty; Adam Szlachetka; Morgan Johnston; Michellie Thurman; Daniel J Munt; Alekha K Dash; Milica Markovic; Arik Dahan; Yazen Alnouti; Alborz Yazdi; Bhavesh D Kevadiya; Siddappa N Byrareddy; Samuel M Cohen; Benson Edagwa; Howard E Gendelman
Journal:  Nat Commun       Date:  2022-06-09       Impact factor: 17.694

2.  Transformation of tenofovir into stable ProTide nanocrystals with long-acting pharmacokinetic profiles.

Authors:  Denise A Cobb; Nathan Smith; Suyash Deodhar; Aditya N Bade; Nagsen Gautam; Bhagya Laxmi Dyavar Shetty; JoEllyn McMillan; Yazen Alnouti; Samuel M Cohen; Howard E Gendelman; Benson Edagwa
Journal:  Nat Commun       Date:  2021-09-16       Impact factor: 14.919

Review 3.  Drug Nanocrystals: Focus on Brain Delivery from Therapeutic to Diagnostic Applications.

Authors:  Elide Zingale; Angela Bonaccorso; Claudia Carbone; Teresa Musumeci; Rosario Pignatello
Journal:  Pharmaceutics       Date:  2022-03-23       Impact factor: 6.525

4.  A Case Report of Subcutaneously Injected Liposomal Cannabidiol Formulation Used as a Compassion Therapy for Pain Management in a Dog.

Authors:  Yael Shilo-Benjamini; Ahuva Cern; Daniel Zilbersheid; Atara Hod; Eran Lavy; Dinorah Barasch; Yechezkel Barenholz
Journal:  Front Vet Sci       Date:  2022-04-28

5.  Modelling intramuscular drug fate in vitro with tissue-relevant biomimetic hydrogels.

Authors:  Adam McCartan; Julia Mackay; David Curran; Randall J Mrsny
Journal:  Int J Pharm X       Date:  2022-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.